Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, carcinoma, epithelial neoplasm, neoplasm, transitional cell carcinoma, urinary bladder disorder, urinary bladder neoplasm, urinary system disorderRecruitingPhase 32026-09-30NCT07566156

2 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Astellas Pharma Global Development, Inc.43
Pfizer431

19 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Compass Oncology - WestTigardUnited States1
Fort Wayne Medical Oncology and HematologyFort WayneUnited States3
Hope and Healing Clinical Research LLCNew LenoxUnited States2
Hope and Healing Clinical Research LLCHinsdaleUnited States4
Illinois Cancer SpecialistsNilesUnited States17
Medical Oncology Hematology ConsultantsNewarkUnited States9
Missouri Cancer AssociatesColumbiaUnited States17
Oncology Hematology Care Clinical Trials, LLCFairfieldUnited States5
Rocky Mountain Cancer CenterAuroraUnited States4
Samsun Clinic - Ridley-Tree Cancer CenterSanta BarbaraUnited States1
Scri Oncology PartnersNashvilleUnited States156
Site CA01071MontrealCanada1
Site KR01065SeoulSouth Korea1
Site KR01113DaeguSouth Korea1
Site TW01117Kaohsiung CityTaiwan1
Texas OncologyAustinUnited States6
Texas Oncology - Northeast TexasTylerUnited States18
Virginia Oncology AssociatesNorfolkUnited States73
Williamette Valley Cancer Institute and Research CenterEugeneUnited States2